drugset / Trial / NCT01250249
A Study of Comparing Safety and Reactogenicity, of Lyophilized BCG Vaccine IP of Green Signal Bio Pharma Private Limited, India With BCG Vaccine of Serum Institute of India Limited in 120 Healthy Children.
RandomizedSingle-groupOpen-labelPrevention
Summary
To compare Safety and Reactogenecity of BCG vaccine of Green Signal Biopharma Private Limited India with BCG vaccine of serum institute of India limited (SIIL), India in 120 healthy children.
Timeline
- Start
- 2008-11
- Primary completion
- 2009-06
- Completion
- 2009-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | BCG Vaccine IP | Vaccine | 0.05 ml | Other |
| Comparator | BCG Vaccine IP | Vaccine | 0.1 mg | Other |
| Comparator | BCG Vaccine IP | Vaccine | 0.1 ml | Other |
Indications
No indication recorded.